You are here

  • Home
  • Archive
  • Volume 24, Issue 3
  • Dual Inhibition of Phosphatidylinositol 3′-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach for Mucinous Adenocarcinoma of the Ovary

Article info

Article menu
Download PDFPDF
Basic Science
Dual Inhibition of Phosphatidylinositol 3′-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach for Mucinous Adenocarcinoma of the Ovary

Authors

  1. Address correspondence and reprint requests to Hiroaki Itamochi, MD, PhD, Department of Obstetrics and Gynecology, Tottori University School of Medicine, 36-1 Nishicho, Yonago 683-8504 Japan. E-mail: itamochi{at}med.tottori-u.ac.jp.

Citation

Kudoh A, Oishi T, Itamochi H, et al
Dual Inhibition of Phosphatidylinositol 3′-Kinase and Mammalian Target of Rapamycin Using NVP-BEZ235 as a Novel Therapeutic Approach for Mucinous Adenocarcinoma of the Ovary
International Journal of Gynecologic Cancer 2014;24:444-453.

Publication history

  • Received September 11, 2013
  • Accepted December 19, 2013
  • First published March 1, 2014.
Online issue publication 
June 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2014 by IGCS and ESGO